In today’s Investor Webinar we talk about:
– Marc & Stuart’s Top Picks week 1: +4.8%. And we have a new addition to the list.
– Cyclopharm (ASX: CYC): FDA approval is coming!
– Our favourite reading in the morning: Appendices 3Y…which directors are buying and selling.
